Arch Ophthalmol. Aug;(8) Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years. Cryotherapy . The most effective proven treatments for ROP are laser therapy or cryotherapy. Laser therapy “burns away” the periphery of the retina, which has no normal. are discussed. Retinopathy of prematurity (ROP) is a leading cause of childhood blindness.’2 Cryotherapy was first used in the treatment of this condition in the.

Author: Malahn Mogor
Country: Estonia
Language: English (Spanish)
Genre: Health and Food
Published (Last): 21 April 2012
Pages: 251
PDF File Size: 13.31 Mb
ePub File Size: 9.6 Mb
ISBN: 517-1-99537-510-8
Downloads: 28900
Price: Free* [*Free Regsitration Required]
Uploader: Taull

Sign in to access your subscriptions Sign in to your personal account. The epidemiological description of patients reaching threshold ROP in the study prior to randomization was an important collection of data and has roop used to develop screening recommendations.

These data remain the best long-term information available about the consequences of ROP with and without treatment against which other ROP interventions are measured. Vitrectomy involves removing the vitreous and replacing it with a saline solution. Scientists believe that the periphery of the retina then sends out signals to other areas of the retina for nourishment. However, at about the same time as the trial, transpupillary laser photocoagulation was introduced as a alternative treatment.

The initial conclusion of the expedited early publications and 3- and month primary outcomes is that cryotherapy for threshold ROP is safe and effective when used in one eye.

Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP).

While ROP treatment decreases the chances for vision loss, it does not always prevent it. In the study, non-physician staff in the NICU were trained to take the photos, which were made available to trained image readers, who evaluated whether the babies needed to be referred for potential treatment. Patients were recruited from admissions to the participating centers, potentially introducing a bias due to their tertiary nature and referral patterns.

Thus, even before the publication of the initial manuscript, many clinicians had adopted screening and treatment guidelines similar to those used in the study in anticipation of favorable results. As for vision, cryotherapy reduced the incidence of unfavorable resolution acuity outcome by By all these measures, CRYO-ROP has been highly successful, both in achieving its formal goals as well as developing information to support a new understanding of ROP and the development of visual impairment in young children.

Transscleral laser photocoagulation has also been reported. The choice of an anatomic outcome was appropriately expedient, allowing earlier analysis, and the benefit of treatment has remained clinically and statistically relevant in subsequent reports of visual function.

A lack of standardized terminology and grading, and especially a lack of comparative clinical trial data, led to the reluctance of many clinicians to embrace this treatment. Long-term results of CRYO-ROP have top influenced the management of affected patients throughout the remainder of childhood, including long-term surveillance for late retinal changes, refractive error, and amblyopia management. Long-term assessment of ocular fundus findings reported over the length of the study have also been very useful in understanding the lifelong anatomical issues related to ROP.

Evaluating the Cryotherapy for Retinopathy of Prematurity Study (CRYO-ROP)

Stage III — Severely abnormal blood vessel growth. Create a free personal account to access your subscriptions, eop up for alerts, and more.

Spanning more than 20 years so far, and involving hundreds of ophthalmologists, neonatologists, photographers, visual acuity testers, and other investigators in 23 clinical centers across the United States, this gargantuan effort has produced high-quality data about the benefits of treatment of retinopathy of prematurity ROP with peripheral retinal ablation as well as the natural history of ROP and the development and measurement of visual function in young children with rlp and visual impairment.

This cohort will likely never be reproduced because as a rule severe ROP is universally treated at the present time. Stage II — Moderately abnormal blood vessel growth.

This important finding led to the development of the ETROP and revised treatment recommendations for earlier treatment of patients with involvement of zone 1. In the case of ROP, patients could present with symmetrical involvement of both eyes, allowing randomization of one eye for treatment and the other for control.

Today, with advances in neonatal care, smaller and more premature infants are being saved. By judicious choice of a threshold for treatment that allowed a statistically and clinically relevant improvement in outcomes, and by choosing outcome measures that were gop expeditious fundus appearance and relevant visual functionthe study planners created a framework for answering the important question of treatment benefits from ablative therapy.

However, the magnitude of the benefit of treatment was exaggerated by this design when compared with top vision outcomes. Create a free personal account to make a comment, download free article PDFs, sign up for alerts and more.

Results of U.S. randomized clinical trial of cryotherapy for ROP (CRYO-ROP).

The paired analysis provides a strong control for environmental covariables in these complex cases with many factors that might influence visual outcomes.

A second examination by a different clinician was used as a measure to control for bias in staging. An ROP epidemic occurred in the s and early s when hospital nurseries began using excessively high levels of oxygen in incubators to save the lives of premature infants. Infants with ROP are considered to be at higher risk for developing certain eye problems later in life, such as retinal detachment, myopia nearsightednessstrabismus crossed eyesamblyopia lazy eyeand glaucoma.

The quality of the data obtained, the study design, and the decision to terminate enrollment early when the benefit of treatment was apparent set standards against which current and future clinical treatment trials will be measured.

Create a personal account to register for email alerts with links to free full-text articles.